Recombinant CVA6 VP1/Capsid protein VP1 Protein, N-His

Catalog No.

YVV19101

Expression system

E. coli

Species

Coxsackievirus A6

Protein length

Asn566-Ser870

Predicted molecular weight

35.81 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

A0A0H3YLW6

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Genome polyprotein, Capsid protein VP1, P1D, Virion protein 1

A single amino acid mutation in VP1 of coxsackievirus A6 determining efficiency of VP0 cleavage and proliferation., PMID:40366174

The Emergence of Coxsackievirus A16 Subgenotype B1c: A Key Driver of the Hand, Foot, and Mouth Disease Epidemic in Guangdong, China., PMID:40006974

Discovery of a broad-spectrum monoclonal antibody recognizing a conserved, linear epitope WFYDGYPT on VP1 protein of Enterovirus A species., PMID:39736634

Evaluation of VP4-VP2 sequencing for molecular typing of human enteroviruses., PMID:39656727

Antiviral activity of povidone-iodine gargle and mouthwash solution against Enterovirus A71, Coxsackieviruses A16, A10 and A6., PMID:39548776

Characterization of cross-reactivity of coxsackievirus A2 VP1-specific polyclonal antibodies with enterovirus A71, coxsackievirus A16, and coxsackievirus A6., PMID:39298881

[Epidemiological and etiological characteristics of herpes pharyngitis in 3 prefectures in Jiangsu Province]., PMID:39004970

First detection of multiple cases related to CV-A16 strain of B1c clade in Beijing in 2022., PMID:38982764

Evolution, recombination and geographic spreading of global Coxsackievirus A6., PMID:38749308

Epidemiological and Genetic Characterization of Coxsackievirus A6-Associated Hand, Foot, and Mouth Disease in Gwangju, South Korea, in 2022., PMID:38543842

Molecular Epidemiology and Evolution of Coxsackievirus A14., PMID:38140564

Molecular epidemiology of hand, foot, and mouth disease in Karnataka, India in 2022., PMID:37945122

Epidemiological and molecular characterization of Coxsackievirus A6 causing hand, foot, and mouth disease in the Philippines, 2012-2017., PMID:37657679

Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model., PMID:36851724

Vertical Transmission of Coxsackievirus A6 with Severe Congenital Pneumonia/Sepsis., PMID:36833540

[Analysis of enterovirus infection type among acute respiratory tract infection cases in Luohe City, Henan Province from 2017 to 2021]., PMID:36655353

Clinical profile and molecular typing of viral etiological agents associated with Hand, Foot and Mouth Disease (HFMD): A study from Udhampur, Northern India., PMID:36470773

Genetic characteristics of Coxsackievirus A6 from children with hand, foot and mouth disease in Beijing, China, 2017-2019., PMID:36257478

Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virion., PMID:36056184

Heat Shock Protein A6 Is Especially Involved in Enterovirus 71 Infection., PMID:35308396

Characterization of Coxsackievirus A6 Strains Isolated From Children With Hand, Foot, and Mouth Disease., PMID:34490141

Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model., PMID:33739899

Molecular strategy for the direct detection and identification of human enteroviruses in clinical specimens associated with hand, foot and mouth disease., PMID:33166321

Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity., PMID:33101238

Molecular epidemiology of enteroviruses associated with severe hand, foot and mouth disease in Shenzhen, China, 2014-2018., PMID:32666145

Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China., PMID:32264839

National Epidemiology and Evolutionary History of Four Hand, Foot and Mouth Disease-Related Enteroviruses in China from 2008 to 2016., PMID:31664644

Molecular epidemiology of enterovirus from children with herpangina or hand, foot, and mouth disease in Hangzhou, 2016., PMID:31321585

The surveillance of the epidemiological and serotype characteristics of hand, foot, mouth disease in Neijiang city, China, 2010-2017: A retrospective study., PMID:31170178

In Vitro and In Vivo Inhibition of the Infectivity of Human Enterovirus 71 by a Sulfonated Food Azo Dye, Brilliant Black BN., PMID:31167919

Recombinant CV-A6 strains related to hand-foot-mouth disease and herpangina at primary care centers (Barcelona, Spain)., PMID:31033351

Molecular characteristic analysis for the VP1 region of coxsackievirus A6 strains isolated in Jiujiang area, China, from 2012 to 2013., PMID:30946358

Phylogenetic and antigenic analyses of coxsackievirus A6 isolates in Yamagata, Japan between 2001 and 2017., PMID:30683510

Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden., PMID:30669973

Atypical hand, foot, and mouth disease caused by Coxsackievirus A6 in Argentina in 2015., PMID:30269935

Molecular epidemiology of coxsackievirus A6 circulating in Hong Kong reveals common neurological manifestations and emergence of novel recombinant groups., PMID:30237097

Molecular epidemiology of coxsackievirus A6 derived from hand, foot, and mouth disease in Fukuoka between 2013 and 2017., PMID:29981169

Identification of recombinant coxsackievirus A6 variants in hand, foot and mouth disease in Nanjing, China, 2013., PMID:29947601

An emerging and expanding clade accounts for the persistent outbreak of Coxsackievirus A6-associated hand, foot, and mouth disease in China since 2013., PMID:29587191

A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles., PMID:29093091

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody., PMID:28894095

Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan., PMID:28771766

Genetic characterization of enterovirus strains identified in Hand, Foot and Mouth Disease (HFMD): Emergence of B1c, C1 subgenotypes, E2 sublineage of CVA16, EV71 and CVA6 strains in India., PMID:28577914

A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012., PMID:27907198

[Genetic Characterization of Coxsackievirus A6 Strains Isolated in Ningxia Region, China, 2013～2015]., PMID:30004200

Molecular epidemiology and the evolution of human coxsackievirus A6., PMID:27692044

Molecular epidemiology of the enteroviruses associated with hand, foot and mouth disease/herpangina in Dongguan, China, 2015., PMID:27654666

Bioinformatic analysis of non-VP1 capsid protein of coxsackievirus A6., PMID:27465341

[Gene Characteristic Analysis for The VP1 Region of Coxsackievirus A6 Associated with HFMD in the Anyang Area of China during 2013]., PMID:29963816

Clinical and Etiological Characteristics of Atypical Hand-Foot-and-Mouth Disease in Children from Chongqing, China: A Retrospective Study., PMID:26693489

Document Download

Recombinant CVA6 VP1/Capsid protein VP1 Protein, N-His.pdf